top of page
  • Doherty Institute

Advancing pandemic preparedness with novel therapeutic platform to combat viral pathogens

Researchers at the Doherty Institute, with collaborators from The University of Queensland’s National Biologics Facility and industry partner Biointelect Pty Ltd, are developing a novel therapeutic platform technology to combat viral pathogens with pandemic potential, thanks to the support of Health Security Systems Australia (HSSA), a division of DMTC limited.

Read the full article from the Doherty Institute here.

Dr Jennifer Juno, Dr Adam Wheatly and Dr Wen Shi Lee, all part of this project (Photo Courtesy of DMTC Limited. Photographer: Cesar Nicolas)


bottom of page